Accelerating innovation with Aurigene’s CDMO services

Aurigene Pharmaceutical Services Limited is a leading contract research, development, and manufacturing organization (CRDMO), offering integrated solutions across discovery, development, and commercial manufacturing. The company partners with global pharmaceutical and biotechnology organizations to support the development of innovative therapies across a range of modalities, including peptides, small molecules and biologics. We support the development and manufacturing of APIs, intermediates, excipients, and formulations in various dosage forms.